obsessive compulsive disorder. Obsessive-compulsive disorder
Conditions
Interventions
Intervention 1: Intervention group: one tablet of dextromethorphan with a dose of 15 mg BID daily are given orally along with the previously used SSRI drug for 90 days from Dana Pharmaceutical Company
Sponsors
Zanjan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients diagnosed with obsessive-compulsive disorder with moderate to high severity (YBOCS>16) Patients who have not responded to 12 weeks of obsessive-compulsive disorder treatment with an adequate dose of an SSRI People over 18 years old People who have filled out informed consent
Exclusion criteria
Exclusion criteria: Comorbidity with other psychiatric disorders except major depressive disorder, including psychotic disorders, substance dependence disorders Pregnancy Severe kidney and liver disease Unstable medical condition
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of Obsessive Compulsive Disorder based on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). Timepoint: Yale-Brown obsessive compulsive scale (Y-BOCS) was measured at the beginning of the study and 30 and 90 days after the start of treatment. Method of measurement: Yale-Brown obsessive compulsive scale (Y-BOCS) Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRomina Bagheri
Zanjan University of Medical Sciences
Outcome results
None listed